TEM.NASDAQTempus Ai, INC

Form 4: Tempus AI Expands Personalis Stake with Multi-Million Dollar Buy

Sentiment:

Insider Trading Report


Tempus AI, a director and 10% owner of Personalis, Inc., reported multiple common stock purchases totaling over $2.5 million in late 2025.

Better than expectedThe filing reports significant insider buying by a director and 10% owner, Tempus AI, Inc., which is generally interpreted as a positive signal of confidence in the company's future performance and valuation.

Summary

  • Tempus AI, Inc., a director and 10% owner of Personalis, Inc. (PSNL), acquired a total of 320,267 shares of Personalis Common Stock through multiple open market purchases.
  • The transactions occurred between November 18, 2025, and December 22, 2025.
  • The purchase prices ranged from a weighted average of $7.67 to $11.00 per share.
  • The total value of the shares purchased is approximately $2,539,188.17.
  • Following these transactions, Tempus AI, Inc. directly beneficially owns 13,039,067 shares of Personalis, Inc. Common Stock.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal. The substantial insider buying by a significant shareholder and director suggests high confidence in Personalis, Inc.'s future, warranting a high sentiment score.

Positives

  • Significant insider buying by Tempus AI, Inc., a director and 10% owner, indicates strong confidence in Personalis, Inc.'s future prospects.
  • The aggregate value of shares purchased exceeds $2.5 million, representing a substantial investment by a key stakeholder.
  • The transactions were made pursuant to a Rule 10b5-1(c) plan, suggesting a pre-planned investment strategy.

Future Outlook

The filing indicates a series of planned purchases under a Rule 10b5-1(c) plan, suggesting a strategic, long-term positive outlook by Tempus AI, Inc. regarding Personalis, Inc.'s future performance.

Management Comments

  • Tempus AI, Inc. undertakes to provide full information regarding the number of shares purchased at each separate price within the reported ranges upon request to the Issuer, any security holder, or the SEC staff.

Industry Context

StockSavvy.ai notes that significant insider buying, especially by a 10% owner and director, often signals strong internal confidence in a company's future prospects, which can be a positive indicator for the market. This activity in the genomics and biotechnology sector could suggest an anticipated positive development or undervaluation of Personalis, Inc. within its competitive landscape.

Comparison to Industry Standards

  • StockSavvy.ai observes that insider purchases of this magnitude (over $2.5 million) are substantial and typically viewed more favorably than smaller, routine transactions, often signaling a strong conviction from a major shareholder.
  • While specific comparable companies or projects are not detailed in this Form 4, such a commitment from a major shareholder like Tempus AI in Personalis, Inc. often outperforms general market sentiment in the short to medium term, assuming the underlying business fundamentals support the conviction.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Rule 10b5-1 Plan AdoptionThe transactions were made pursuant to a contract, instruction, or written plan for the purchase of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).NAIndicates a pre-arranged, systematic approach to insider trading, which can mitigate concerns about opportunistic timing and suggests a long-term investment perspective.

Related Party Transactions

  • Tempus AI, Inc. is identified as both a Director and a 10% Owner of Personalis, Inc., making these transactions related-party dealings.

Stakeholder Impact

  • Shareholders may view this as a positive indicator, potentially increasing investor confidence and demand for Personalis, Inc. stock.
  • Employees and management might interpret this as a vote of confidence from a major investor, potentially boosting morale.

Key Dates

DateDescription
11/18/2025Acquisition of 64,750 shares of Common Stock at a weighted average price of $7.67.
11/19/2025Acquisition of 30,645 shares of Common Stock at a weighted average price of $8.12.
11/20/2025Acquisition of 28,827 shares of Common Stock at a weighted average price of $8.63.
11/21/2025Acquisition of 9,900 shares of Common Stock at a weighted average price of $8.84.
11/21/2025Acquisition of 16,599 shares of Common Stock at a weighted average price of $9.74.
11/24/2025Acquisition of 25,225 shares of Common Stock at a weighted average price of $9.87.
11/25/2025Acquisition of 9,712 shares of Common Stock at a weighted average price of $10.08.
11/25/2025Acquisition of 13,888 shares of Common Stock at a weighted average price of $11.00.
12/17/2025Acquisition of 31,650 shares of Common Stock at a weighted average price of $7.86.
12/18/2025Acquisition of 31,430 shares of Common Stock at a weighted average price of $7.91.
12/19/2025Acquisition of 29,641 shares of Common Stock at a weighted average price of $8.39.
12/22/2025Acquisition of 28,000 shares of Common Stock at a weighted average price of $8.93.
02/13/2026Date of filing signature by Andrew Polovin, General Counsel for Tempus AI, Inc.

Recommendation

strong buy

The significant insider buying by Tempus AI, Inc., a director and 10% owner of Personalis, Inc., signals strong conviction in the company's prospects. Such substantial investment by a well-informed party, especially under a 10b5-1 plan, suggests an expectation of future value appreciation. This action provides a compelling reason for investors to consider a 'strong buy' position, aligning with the insider's demonstrated confidence.

Keywords

Personalis, PSNL, Tempus AI, Insider Buying, Stock Purchase, Form 4, Equity Acquisition, Biotechnology, Genomics

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.